Search research articles
Contact Us
Filters
Showing results (101-110 of 124) with videos related to
Page
of 13
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 1, 2019
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study
Zachariah DeFilipp, Richard Ancheta, Ying Liu, et al.
Leukemia & Lymphoma
|
July 15, 2020
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients
Bei Hu, Xiao Lin, Hans C Lee, et al.
The Lancet. Haematology
|
August 12, 2023
Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts
Rory M Shallis, Naval Daver, Jessica K Altman, et al.
Leukemia
|
October 31, 2022
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
Transplantation and Cellular Therapy
|
August 17, 2021
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes
Betül Oran, Kwang Woo Ahn, Caitrin Fretham, et al.
Leukemia
|
March 23, 2023
Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
JAMA Oncology
|
January 13, 2022
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors
Guru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, et al.
Transplantation and Cellular Therapy
|
August 24, 2021
Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults
Leland Metheny, Natalie S Callander, Aric C Hall, et al.
Blood Advances
|
May 3, 2023
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis
Roni Tamari, Donal P McLornan, Kwang Woo Ahn, et al.
Transplantation and Cellular Therapy
|
October 3, 2020
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study
Nelli Bejanyan, Meijie Zhang, Khalid Bo-Subait, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 124) with videos related to
Sort By:
Page
of 13
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 1, 2019
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study
Zachariah DeFilipp, Richard Ancheta, Ying Liu, et al.
Leukemia & Lymphoma
|
July 15, 2020
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients
Bei Hu, Xiao Lin, Hans C Lee, et al.
The Lancet. Haematology
|
August 12, 2023
Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts
Rory M Shallis, Naval Daver, Jessica K Altman, et al.
Leukemia
|
October 31, 2022
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
Transplantation and Cellular Therapy
|
August 17, 2021
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes
Betül Oran, Kwang Woo Ahn, Caitrin Fretham, et al.
Leukemia
|
March 23, 2023
Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
JAMA Oncology
|
January 13, 2022
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors
Guru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, et al.
Transplantation and Cellular Therapy
|
August 24, 2021
Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults
Leland Metheny, Natalie S Callander, Aric C Hall, et al.
Blood Advances
|
May 3, 2023
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis
Roni Tamari, Donal P McLornan, Kwang Woo Ahn, et al.
Transplantation and Cellular Therapy
|
October 3, 2020
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study
Nelli Bejanyan, Meijie Zhang, Khalid Bo-Subait, et al.
Page
of 13